omega-n-methylarginine has been researched along with Choriocarcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hitsumoto, Y; Kitagawa, H; Matsuura, S; Saheki, S; Yano, J | 1 |
1 other study(ies) available for omega-n-methylarginine and Choriocarcinoma
| Article | Year |
|---|---|
Attenuation of human chorionic gonadotropin release by nitric oxide in choriocarcinoma cell lines.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Arginine; Blotting, Western; Choriocarcinoma; Chorionic Gonadotropin; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Hemoglobin A; Humans; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Tumor Cells, Cultured; Uterine Neoplasms | 1996 |